Year-end Report 2021 Redsense Medical AB (publ)
October – December 2021 · Net sales amounted to kSEK 4,059 (2,228), an increase by 82 percent. · Operating loss, EBIT amounted to kSEK 3,073 (4,716). · Result after tax amounted to kSEK -733 (-5,610). · Earnings per share was SEK -0.05(-0.40) before and after dilution. January – December 2021 · Net sales amounted to kSEK 9,362 (14,442), a decrease by 35 percent. · Operating loss, EBIT amounted to kSEK 11,991 (8,124). · Result after tax amounted to kSEK -7,972 (-9,035). · Earnings per share was SEK -0.57 (-0.64) before and after dilution. · Net cash at